Andrew B. West

Andrew B. West

Auto-generated profile, based on publicly available information

Andrew B. West

Duke University

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AWAndrew B. West
Andrew B. West
DMDarren J. Moore
Darren J. Moore
SBSaskia Biskup
Saskia Biskup
ABArtem Bugayenko
Artem Bugayenko
WSWanli W. Smith
Wanli W. Smith
Ted DawsonTed Dawson
Ted Dawson
Mutations in the leucine-rich repeat kinase 2 gene ( LRRK2 ) cause late-onset Parkinson's disease (PD) with a clinical appearance indistinguishable from idiopathic PD. Initial studies suggest that LRRK2 mutations are the most common yet identified determinant of PD susceptibility, transmitted in an autosomal-dominant mode of inheritance. Herein, we characterize the LRRK2 gene and transcript in human brain and subclone the predominant ORF. Exogenously expressed LRRK2 protein migrates at ≈280 kDa and is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Familial-linked mutations G2019S or R1441C do not have an obvious effect on protein steady-state levels, turnover, or localization. However, in vitro kinase assays using full-length recombinant LRRK2 reveal an increase in activity caused by familial-linked mutations in both autophosphorylation and the phosphorylation of a generic substrate. These results suggest a gain-of-function mechanism for LRRK2 -linked disease with a central role for kinase activity in the development of PD.

21 July 2005 in Annual Review of Neuroscience
Verified
Journal Article
Closed access
DMDarren J. Moore
Darren J. Moore
AWAndrew B. West
Andrew B. West
VDValina L. Dawson
Valina L. Dawson
Ted DawsonTed Dawson
Ted Dawson
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic neurons in the substantia nigra. Although the etiology of PD is incompletely understood, the recent discovery of genes associated with rare monogenic forms of the disease, together with earlier studies and new experimental animal models, has provided important and novel insight into the molecular pathways involved in disease pathogenesis. Increasing evidence indicates that deficits in mitochondrial function, oxidative and nitrosative stress, the accumulation of aberrant or misfolded proteins, and ubiquitin-proteasome system dysfunction may represent the principal molecular pathways or events that commonly underlie the pathogenesis of sporadic and familial forms of PD .

3 February 2025 in Nature Medicine
Verified
Journal Article
Open access
PDF file
ANAlexander J. Nihart
Alexander J. Nihart
MGMarcus A. Garcia
Marcus A. Garcia
EHEliane El Hayek
Eliane El Hayek
RLRui Liu
Rui Liu
MOMarian Olewine
Marian Olewine
MCMatthew J. Campen
Matthew J. Campen
Rising global concentrations of environmental microplastics and nanoplastics (MNPs) drive concerns for human exposure and health outcomes. Complementary methods for the robust detection of tissue MNPs, including pyrolysis gas chromatography–mass spectrometry, attenuated total reflectance–Fourier transform infrared spectroscopy and electron microscopy with energy-dispersive spectroscopy, confirm the presence of MNPs in human kidney, liver and brain. MNPs in these organs primarily consist of polyethylene, with lesser but significant concentrations of other polymers. Brain tissues harbor higher proportions of polyethylene compared to the composition of the plastics in liver or kidney, and electron microscopy verified the nature of the isolated brain MNPs, which present largely as nanoscale shard-like fragments. Plastic concentrations in these decedent tissues were not influenced by age, sex, race/ethnicity or cause of death; the time of death (2016 versus 2024) was a significant factor, with increasing MNP concentrations over time in both liver and brain samples (P = 0.01). Finally, even greater accumulation of MNPs was observed in a cohort of decedent brains with documented dementia diagnosis, with notable deposition in cerebrovascular walls and immune cells. These results highlight a critical need to better understand the routes of exposure, uptake and clearance pathways and potential health consequences of plastics in human tissues, particularly in the brain.

2 January 2007 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
AWAndrew B. West
Andrew B. West
DMDarren J. Moore
Darren J. Moore
CCCatherine Choi
Catherine Choi
SAShaida A. Andrabi
Shaida A. Andrabi
XLXiaojie Li
Xiaojie Li
Ted DawsonTed Dawson
Ted Dawson
Mutations in the leucine-rich repeat kinase 2 gene ( LRRK2 ) cause late-onset Parkinson's disease indistinguishable from idiopathic disease. The mechanisms whereby missense alterations in the LRRK2 gene initiate neurodegeneration remain unknown. Here, we demonstrate that seven of 10 suspected familial-linked mutations result in increased kinase activity. Functional and disease-associated mutations in conserved residues reveal the critical link between intrinsic guanosine triphosphatase (GTPase) activity and downstream kinase activity. LRRK2 kinase activity requires GTPase activity, whereas GTPase activity functions independently of kinase activity. Both LRRK2 kinase and GTPase activity are required for neurotoxicity and potentiate peroxide-induced cell death, although LRRK2 does not function as a canonical MAP–kinase–kinase–kinase. These results suggest a link between LRRK2 kinase activity and pathogenic mechanisms relating to neurodegeneration, further supporting a gain-of-function role for LRRK2 mutations.

10 December 2014 in Nature Communications
Verified
Journal Article
Open access
SGSimone Gupta
Simone Gupta
SEShannon E. Ellis
Shannon E. Ellis
FAForam N. Ashar
Foram N. Ashar
AMAnna Moes
Anna Moes
JBJoel S. Bader
Joel S. Bader
DADan E. Arking
Dan E. Arking
Recent studies of genomic variation associated with autism have suggested the existence of extreme heterogeneity. Large-scale transcriptomics should complement these results to identify core molecular pathways underlying autism. Here we report results from a large-scale RNA sequencing effort, utilizing region-matched autism and control brains to identify neuronal and microglial genes robustly dysregulated in autism cortical brain. Remarkably, we note that a gene expression module corresponding to M2-activation states in microglia is negatively correlated with a differentially expressed neuronal module, implicating dysregulated microglial responses in concert with altered neuronal activity-dependent genes in autism brains. These observations provide pathways and candidate genes that highlight the interplay between innate immunity and neuronal activity in the aetiology of autism.

21 November 2006 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
SBSaskia Biskup
Saskia Biskup
DMDarren J. Moore
Darren J. Moore
Fulvio CelsiFulvio Celsi
Fulvio Celsi
SHShinji Higashi
Shinji Higashi
AWAndrew B. West
Andrew B. West
VDValina L. Dawson
Valina L. Dawson